Hereby, evasion of apoptosis through the inactivation of p53 pathways essentially contributes to hallmarks of cancer including sustained cell proliferation, inappropriate cell cycle arrest, loss of genomic integrity, and therapy resistance in CRC [156]. This evidence concerns the gene TP53 and cancer.